Mapping ‘psychedelic trips’ in the brain to better direct their therapeutic effects

By The Conversation | April 4, 2022

For the past sev­er­al decades, psy­che­delics have been wide­ly stig­ma­tized as dan­ger­ous ille­gal drugs. But a recent surge of aca­d­e­m­ic research into their use to treat psy­chi­atric con­di­tions is spurring a recent shift in pub­lic opin­ion. Psy­che­delics are psy­chotrop­ic drugs: sub­stances that affect your men­tal state. Oth­er types of psy­chotrop­ics include anti­de­pres­sants and anti-anx­i­e­ty medications.…

Read More

Therapy or antidepressants? Coming soon: Brain activity “fingerprints” to personalize depression treatments

By SharpBrains | January 9, 2015

. To Treat Depres­sion, Drugs or Ther­a­py? (The New York Times): “Until recent­ly, many experts thought that your clin­i­cian could lit­er­al­ly pick any anti­de­pres­sant or type of psy­chother­a­py at ran­dom because, with a few clin­i­cal excep­tions, there was lit­tle evi­dence to favor one treat­ment over anoth­er for a giv­en patient

Read More